nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNQ4—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0672	0.162	CbGeAlD
Dalfampridine—KCNQ1—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0386	0.0929	CbGeAlD
Dalfampridine—KCNQ4—cochlea—peripheral nervous system neoplasm	0.034	0.0819	CbGeAlD
Dalfampridine—KCNQ4—internal ear—peripheral nervous system neoplasm	0.0323	0.0776	CbGeAlD
Dalfampridine—KCNQ1—cochlea—peripheral nervous system neoplasm	0.0196	0.047	CbGeAlD
Dalfampridine—KCNC2—ganglion—peripheral nervous system neoplasm	0.019	0.0457	CbGeAlD
Dalfampridine—KCNQ1—internal ear—peripheral nervous system neoplasm	0.0185	0.0446	CbGeAlD
Dalfampridine—KCNC1—nerve—peripheral nervous system neoplasm	0.0137	0.0329	CbGeAlD
Dalfampridine—KCNH6—ganglion—peripheral nervous system neoplasm	0.00963	0.0232	CbGeAlD
Dalfampridine—KCNA1—nerve—peripheral nervous system neoplasm	0.00816	0.0196	CbGeAlD
Dalfampridine—KCNH8—trigeminal ganglion—peripheral nervous system neoplasm	0.00805	0.0194	CbGeAlD
Dalfampridine—KCNA4—trigeminal ganglion—peripheral nervous system neoplasm	0.0076	0.0183	CbGeAlD
Dalfampridine—KCNS1—trigeminal ganglion—peripheral nervous system neoplasm	0.00723	0.0174	CbGeAlD
Dalfampridine—KCND1—trigeminal ganglion—peripheral nervous system neoplasm	0.00691	0.0166	CbGeAlD
Dalfampridine—KCNC3—brainstem—peripheral nervous system neoplasm	0.00691	0.0166	CbGeAlD
Dalfampridine—KCNC1—trigeminal ganglion—peripheral nervous system neoplasm	0.00664	0.016	CbGeAlD
Dalfampridine—KCNA2—brainstem—peripheral nervous system neoplasm	0.0064	0.0154	CbGeAlD
Dalfampridine—KCNG2—cerebellum—peripheral nervous system neoplasm	0.00631	0.0152	CbGeAlD
Dalfampridine—KCND1—brainstem—peripheral nervous system neoplasm	0.00612	0.0147	CbGeAlD
Dalfampridine—KCNC1—brainstem—peripheral nervous system neoplasm	0.00588	0.0141	CbGeAlD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—MXI1—peripheral nervous system neoplasm	0.00546	0.0295	CbGpPWpGaD
Dalfampridine—KCNS3—trigeminal ganglion—peripheral nervous system neoplasm	0.00518	0.0125	CbGeAlD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00496	0.0268	CbGpPWpGaD
Dalfampridine—KCNS3—parotid gland—peripheral nervous system neoplasm	0.00489	0.0118	CbGeAlD
Dalfampridine—KCNQ2—brainstem—peripheral nervous system neoplasm	0.00422	0.0102	CbGeAlD
Dalfampridine—KCNH1—cerebellum—peripheral nervous system neoplasm	0.00407	0.00978	CbGeAlD
Dalfampridine—KCND2—brainstem—peripheral nervous system neoplasm	0.004	0.00962	CbGeAlD
Dalfampridine—KCNA1—trigeminal ganglion—peripheral nervous system neoplasm	0.00396	0.00953	CbGeAlD
Dalfampridine—KCNQ3—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00377	0.0204	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00377	0.0204	CbGpPWpGaD
Dalfampridine—KCNH3—cerebellum—peripheral nervous system neoplasm	0.00362	0.00872	CbGeAlD
Dalfampridine—KCNG1—cerebellum—peripheral nervous system neoplasm	0.00362	0.00872	CbGeAlD
Dalfampridine—KCNS3—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—GNAS—peripheral nervous system neoplasm	0.00352	0.019	CbGpPWpGaD
Dalfampridine—KCNG2—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—GNAS—peripheral nervous system neoplasm	0.00352	0.019	CbGpPWpGaD
Dalfampridine—KCNC2—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—GNAS—peripheral nervous system neoplasm	0.00352	0.019	CbGpPWpGaD
Dalfampridine—KCNH8—cerebellum—peripheral nervous system neoplasm	0.00351	0.00845	CbGeAlD
Dalfampridine—KCNA1—brainstem—peripheral nervous system neoplasm	0.0035	0.00843	CbGeAlD
Dalfampridine—KCND3—brainstem—peripheral nervous system neoplasm	0.00349	0.00839	CbGeAlD
Dalfampridine—KCNC3—cerebellum—peripheral nervous system neoplasm	0.00341	0.0082	CbGeAlD
Dalfampridine—KCNB1—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—GNAS—peripheral nervous system neoplasm	0.00334	0.018	CbGpPWpGaD
Dalfampridine—KCNA4—cerebellum—peripheral nervous system neoplasm	0.00332	0.00798	CbGeAlD
Dalfampridine—KCNA3—cerebellum—peripheral nervous system neoplasm	0.00332	0.00798	CbGeAlD
Dalfampridine—KCNA2—cerebellum—peripheral nervous system neoplasm	0.00315	0.00759	CbGeAlD
Dalfampridine—KCNC4—cerebellum—peripheral nervous system neoplasm	0.00302	0.00726	CbGeAlD
Dalfampridine—KCND1—cerebellum—peripheral nervous system neoplasm	0.00302	0.00726	CbGeAlD
Dalfampridine—KCNH7—cerebellum—peripheral nervous system neoplasm	0.0029	0.00697	CbGeAlD
Dalfampridine—KCNQ4—cerebellum—peripheral nervous system neoplasm	0.0029	0.00697	CbGeAlD
Dalfampridine—KCNC1—cerebellum—peripheral nervous system neoplasm	0.0029	0.00697	CbGeAlD
Dalfampridine—KCNG2—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00269	0.0146	CbGpPWpGaD
Dalfampridine—KCNC2—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00269	0.0146	CbGpPWpGaD
Dalfampridine—KCNS3—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00269	0.0146	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.00258	0.014	CbGpPWpGaD
Dalfampridine—KCNF1—cerebellum—peripheral nervous system neoplasm	0.00258	0.00621	CbGeAlD
Dalfampridine—KCNB1—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00255	0.0138	CbGpPWpGaD
Dalfampridine—KCNQ3—cerebellum—peripheral nervous system neoplasm	0.00226	0.00544	CbGeAlD
Dalfampridine—KCNA3—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.0022	0.0119	CbGpPWpGaD
Dalfampridine—KCNG2—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00217	0.0117	CbGpPWpGaD
Dalfampridine—KCNC2—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00217	0.0117	CbGpPWpGaD
Dalfampridine—KCNS3—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00217	0.0117	CbGpPWpGaD
Dalfampridine—KCNS3—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00212	0.0115	CbGpPWpGaD
Dalfampridine—KCNC2—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00212	0.0115	CbGpPWpGaD
Dalfampridine—KCNG2—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00212	0.0115	CbGpPWpGaD
Dalfampridine—KCNQ2—cerebellum—peripheral nervous system neoplasm	0.00208	0.00501	CbGeAlD
Dalfampridine—KCNB1—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00206	0.0111	CbGpPWpGaD
Dalfampridine—KCNB1—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00201	0.0109	CbGpPWpGaD
Dalfampridine—KCND2—cerebellum—peripheral nervous system neoplasm	0.00197	0.00474	CbGeAlD
Dalfampridine—KCNQ3—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00184	0.00995	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00184	0.00995	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00184	0.00993	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.00179	0.00968	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00179	0.00447	CcSEcCtD
Dalfampridine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00178	0.00447	CcSEcCtD
Dalfampridine—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00177	0.00444	CcSEcCtD
Dalfampridine—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00177	0.00444	CcSEcCtD
Dalfampridine—Infection—Melphalan—peripheral nervous system neoplasm	0.00177	0.00444	CcSEcCtD
Dalfampridine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00177	0.00443	CcSEcCtD
Dalfampridine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00175	0.00439	CcSEcCtD
Dalfampridine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00175	0.00439	CcSEcCtD
Dalfampridine—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00438	CcSEcCtD
Dalfampridine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00173	0.00434	CcSEcCtD
Dalfampridine—KCNA1—cerebellum—peripheral nervous system neoplasm	0.00173	0.00416	CbGeAlD
Dalfampridine—KCND3—cerebellum—peripheral nervous system neoplasm	0.00172	0.00413	CbGeAlD
Dalfampridine—KCNS3—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.0017	0.00922	CbGpPWpGaD
Dalfampridine—KCNC2—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.0017	0.00922	CbGpPWpGaD
Dalfampridine—KCNG2—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.0017	0.00922	CbGpPWpGaD
Dalfampridine—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00423	CcSEcCtD
Dalfampridine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00169	0.00423	CcSEcCtD
Dalfampridine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00169	0.00423	CcSEcCtD
Dalfampridine—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.00168	0.00422	CcSEcCtD
Dalfampridine—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.00168	0.0042	CcSEcCtD
Dalfampridine—Infestation—Etoposide—peripheral nervous system neoplasm	0.00168	0.0042	CcSEcCtD
Dalfampridine—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.00167	0.00419	CcSEcCtD
Dalfampridine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00167	0.00417	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.00164	0.00887	CbGpPWpGaD
Dalfampridine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00164	0.0041	CcSEcCtD
Dalfampridine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00163	0.00409	CcSEcCtD
Dalfampridine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00163	0.00409	CcSEcCtD
Dalfampridine—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.00163	0.00407	CcSEcCtD
Dalfampridine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00162	0.00407	CcSEcCtD
Dalfampridine—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.00162	0.00406	CcSEcCtD
Dalfampridine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00162	0.00406	CcSEcCtD
Dalfampridine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.00406	CcSEcCtD
Dalfampridine—KCNB1—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00162	0.00874	CbGpPWpGaD
Dalfampridine—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.00161	0.00404	CcSEcCtD
Dalfampridine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00403	CcSEcCtD
Dalfampridine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00403	CcSEcCtD
Dalfampridine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.0016	0.00401	CcSEcCtD
Dalfampridine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.0016	0.00401	CcSEcCtD
Dalfampridine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00159	0.00398	CcSEcCtD
Dalfampridine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00159	0.00398	CcSEcCtD
Dalfampridine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00159	0.00398	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00157	0.00394	CcSEcCtD
Dalfampridine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.00394	CcSEcCtD
Dalfampridine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00157	0.00393	CcSEcCtD
Dalfampridine—Back pain—Vincristine—peripheral nervous system neoplasm	0.00156	0.00392	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00391	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00391	CcSEcCtD
Dalfampridine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00156	0.0039	CcSEcCtD
Dalfampridine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00154	0.00387	CcSEcCtD
Dalfampridine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00154	0.00387	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00154	0.00386	CcSEcCtD
Dalfampridine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.0015	0.00376	CcSEcCtD
Dalfampridine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00149	0.00373	CcSEcCtD
Dalfampridine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00149	0.00373	CcSEcCtD
Dalfampridine—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00148	0.00371	CcSEcCtD
Dalfampridine—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00148	0.00371	CcSEcCtD
Dalfampridine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00147	0.00367	CcSEcCtD
Dalfampridine—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.00145	0.0035	CbGeAlD
Dalfampridine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00364	CcSEcCtD
Dalfampridine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00145	0.00362	CcSEcCtD
Dalfampridine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00144	0.00359	CcSEcCtD
Dalfampridine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00144	0.00359	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00143	0.00772	CbGpPWpGaD
Dalfampridine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00358	CcSEcCtD
Dalfampridine—KCNQ3—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00142	0.0077	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00142	0.0077	CbGpPWpGaD
Dalfampridine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00142	0.00356	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00142	0.00355	CcSEcCtD
Dalfampridine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00142	0.00355	CcSEcCtD
Dalfampridine—KCNH4—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00142	0.00765	CbGpPWpGaD
Dalfampridine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.0014	0.00351	CcSEcCtD
Dalfampridine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00346	CcSEcCtD
Dalfampridine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00343	CcSEcCtD
Dalfampridine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00136	0.00342	CcSEcCtD
Dalfampridine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00341	CcSEcCtD
Dalfampridine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00136	0.0034	CcSEcCtD
Dalfampridine—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00136	0.00339	CcSEcCtD
Dalfampridine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.00336	CcSEcCtD
Dalfampridine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00134	0.00336	CcSEcCtD
Dalfampridine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00134	0.00335	CcSEcCtD
Dalfampridine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00133	0.00333	CcSEcCtD
Dalfampridine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.00333	CcSEcCtD
Dalfampridine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.00333	CcSEcCtD
Dalfampridine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00132	0.0033	CcSEcCtD
Dalfampridine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00131	0.00329	CcSEcCtD
Dalfampridine—Infection—Vincristine—peripheral nervous system neoplasm	0.00131	0.00328	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00131	0.00708	CbGpPWpGaD
Dalfampridine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00131	0.00327	CcSEcCtD
Dalfampridine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0013	0.00325	CcSEcCtD
Dalfampridine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0013	0.00325	CcSEcCtD
Dalfampridine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00129	0.00324	CcSEcCtD
Dalfampridine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00128	0.0032	CcSEcCtD
Dalfampridine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.0032	CcSEcCtD
Dalfampridine—Back pain—Etoposide—peripheral nervous system neoplasm	0.00127	0.00317	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00126	0.00682	CbGpPWpGaD
Dalfampridine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00124	0.0031	CcSEcCtD
Dalfampridine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.0031	CcSEcCtD
Dalfampridine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00123	0.00309	CcSEcCtD
Dalfampridine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00308	CcSEcCtD
Dalfampridine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00306	CcSEcCtD
Dalfampridine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00122	0.00305	CcSEcCtD
Dalfampridine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00304	CcSEcCtD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.00121	0.00655	CbGpPWpGaD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00303	CcSEcCtD
Dalfampridine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00302	CcSEcCtD
Dalfampridine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0012	0.00302	CcSEcCtD
Dalfampridine—KCNQ5—Neuronal System—BCHE—peripheral nervous system neoplasm	0.0012	0.00651	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—BCHE—peripheral nervous system neoplasm	0.0012	0.00651	CbGpPWpGaD
Dalfampridine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00299	CcSEcCtD
Dalfampridine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00299	CcSEcCtD
Dalfampridine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00119	0.00299	CcSEcCtD
Dalfampridine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00118	0.00297	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00296	CcSEcCtD
Dalfampridine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00293	CcSEcCtD
Dalfampridine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00292	CcSEcCtD
Dalfampridine—Infection—Cisplatin—peripheral nervous system neoplasm	0.00116	0.0029	CcSEcCtD
Dalfampridine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00116	0.0029	CcSEcCtD
Dalfampridine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00288	CcSEcCtD
Dalfampridine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00288	CcSEcCtD
Dalfampridine—Rash—Topotecan—peripheral nervous system neoplasm	0.00115	0.00288	CcSEcCtD
Dalfampridine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00115	0.00287	CcSEcCtD
Dalfampridine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00286	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00114	0.00617	CbGpPWpGaD
Dalfampridine—Headache—Topotecan—peripheral nervous system neoplasm	0.00114	0.00286	CcSEcCtD
Dalfampridine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00285	CcSEcCtD
Dalfampridine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00285	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00114	0.00285	CcSEcCtD
Dalfampridine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00285	CcSEcCtD
Dalfampridine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00285	CcSEcCtD
Dalfampridine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00113	0.00284	CcSEcCtD
Dalfampridine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00113	0.00284	CcSEcCtD
Dalfampridine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00113	0.00284	CcSEcCtD
Dalfampridine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00113	0.00283	CcSEcCtD
Dalfampridine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.00283	CcSEcCtD
Dalfampridine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00283	CcSEcCtD
Dalfampridine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00113	0.00283	CcSEcCtD
Dalfampridine—Rash—Melphalan—peripheral nervous system neoplasm	0.00112	0.00282	CcSEcCtD
Dalfampridine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00112	0.00281	CcSEcCtD
Dalfampridine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00111	0.00279	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00111	0.00277	CcSEcCtD
Dalfampridine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00273	CcSEcCtD
Dalfampridine—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00273	CcSEcCtD
Dalfampridine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00272	CcSEcCtD
Dalfampridine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00272	CcSEcCtD
Dalfampridine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00108	0.00271	CcSEcCtD
Dalfampridine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00108	0.0027	CcSEcCtD
Dalfampridine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00107	0.00269	CcSEcCtD
Dalfampridine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00107	0.00269	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.00107	0.00578	CbGpPWpGaD
Dalfampridine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00107	0.00268	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00107	0.00576	CbGpPWpGaD
Dalfampridine—Infection—Etoposide—peripheral nervous system neoplasm	0.00106	0.00266	CcSEcCtD
Dalfampridine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00106	0.00265	CcSEcCtD
Dalfampridine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00106	0.00265	CcSEcCtD
Dalfampridine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00262	CcSEcCtD
Dalfampridine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00104	0.0026	CcSEcCtD
Dalfampridine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00104	0.0026	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00102	0.0055	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00102	0.0055	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00102	0.00549	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00102	0.00549	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00102	0.00549	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00253	CcSEcCtD
Dalfampridine—KCNC2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00101	0.00545	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00101	0.00545	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00101	0.00545	CbGpPWpGaD
Dalfampridine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00253	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00252	CcSEcCtD
Dalfampridine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000999	0.0025	CcSEcCtD
Dalfampridine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000982	0.00246	CcSEcCtD
Dalfampridine—KCND3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000981	0.0053	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000972	0.00243	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000963	0.00521	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000961	0.00241	CcSEcCtD
Dalfampridine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00096	0.0024	CcSEcCtD
Dalfampridine—KCNB1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000956	0.00517	CbGpPWpGaD
Dalfampridine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000953	0.00239	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000951	0.00514	CbGpPWpGaD
Dalfampridine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000947	0.00237	CcSEcCtD
Dalfampridine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000939	0.00235	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000939	0.00235	CcSEcCtD
Dalfampridine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000939	0.00235	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000934	0.00505	CbGpPWpGaD
Dalfampridine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000931	0.00233	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000923	0.00231	CcSEcCtD
Dalfampridine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000914	0.00229	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000913	0.00229	CcSEcCtD
Dalfampridine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000905	0.00227	CcSEcCtD
Dalfampridine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000881	0.00221	CcSEcCtD
Dalfampridine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000877	0.0022	CcSEcCtD
Dalfampridine—KCND2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000874	0.00473	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000874	0.00473	CbGpPWpGaD
Dalfampridine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000872	0.00218	CcSEcCtD
Dalfampridine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000871	0.00218	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000869	0.00218	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000869	0.00218	CcSEcCtD
Dalfampridine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000863	0.00216	CcSEcCtD
Dalfampridine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000862	0.00216	CcSEcCtD
Dalfampridine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000859	0.00215	CcSEcCtD
Dalfampridine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000858	0.00215	CcSEcCtD
Dalfampridine—KCNH6—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000858	0.00464	CbGpPWpGaD
Dalfampridine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000849	0.00213	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000845	0.00212	CcSEcCtD
Dalfampridine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000839	0.0021	CcSEcCtD
Dalfampridine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000837	0.0021	CcSEcCtD
Dalfampridine—Rash—Vincristine—peripheral nervous system neoplasm	0.000832	0.00208	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000831	0.00449	CbGpPWpGaD
Dalfampridine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000831	0.00208	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000829	0.00208	CcSEcCtD
Dalfampridine—Headache—Vincristine—peripheral nervous system neoplasm	0.000826	0.00207	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000819	0.00443	CbGpPWpGaD
Dalfampridine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000813	0.00204	CcSEcCtD
Dalfampridine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000787	0.00197	CcSEcCtD
Dalfampridine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000784	0.00196	CcSEcCtD
Dalfampridine—KCNA1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000776	0.00419	CbGpPWpGaD
Dalfampridine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000767	0.00192	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000767	0.00192	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000765	0.00192	CcSEcCtD
Dalfampridine—KCNH7—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000764	0.00413	CbGpPWpGaD
Dalfampridine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000762	0.00191	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00076	0.0019	CcSEcCtD
Dalfampridine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000742	0.00186	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000739	0.00185	CcSEcCtD
Dalfampridine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000736	0.00184	CcSEcCtD
Dalfampridine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000735	0.00184	CcSEcCtD
Dalfampridine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00071	0.00178	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.00177	CcSEcCtD
Dalfampridine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000707	0.00177	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000705	0.00176	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000703	0.00176	CcSEcCtD
Dalfampridine—KCNQ3—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000696	0.00376	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000696	0.00376	CbGpPWpGaD
Dalfampridine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000693	0.00174	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000686	0.00371	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000686	0.00371	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000686	0.00371	CbGpPWpGaD
Dalfampridine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000684	0.00171	CcSEcCtD
Dalfampridine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000679	0.0017	CcSEcCtD
Dalfampridine—Rash—Etoposide—peripheral nervous system neoplasm	0.000674	0.00169	CcSEcCtD
Dalfampridine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000673	0.00169	CcSEcCtD
Dalfampridine—Headache—Etoposide—peripheral nervous system neoplasm	0.00067	0.00168	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000657	0.00165	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000651	0.00352	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00065	0.00351	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00065	0.00351	CbGpPWpGaD
Dalfampridine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000636	0.00159	CcSEcCtD
Dalfampridine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000635	0.00159	CcSEcCtD
Dalfampridine—KCNH2—cerebellum—peripheral nervous system neoplasm	0.000635	0.00153	CbGeAlD
Dalfampridine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000625	0.00156	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000623	0.00156	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000621	0.00155	CcSEcCtD
Dalfampridine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000604	0.00151	CcSEcCtD
Dalfampridine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000599	0.0015	CcSEcCtD
Dalfampridine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000595	0.00149	CcSEcCtD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000594	0.00321	CbGpPWpGaD
Dalfampridine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.00147	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000587	0.00147	CcSEcCtD
Dalfampridine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000582	0.00146	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000578	0.00145	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000576	0.00144	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.00144	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00056	0.0014	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.0014	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.00139	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.00138	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000544	0.00136	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000542	0.00136	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000538	0.00135	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000538	0.00135	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000534	0.00134	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000533	0.00288	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000529	0.00286	CbGpPWpGaD
Dalfampridine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000527	0.00132	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.0013	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000517	0.0013	CcSEcCtD
Dalfampridine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000512	0.00128	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000502	0.00272	CbGpPWpGaD
Dalfampridine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.00126	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.00125	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000497	0.00268	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000497	0.00268	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GNS—peripheral nervous system neoplasm	0.000496	0.00268	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GNS—peripheral nervous system neoplasm	0.000496	0.00268	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GNS—peripheral nervous system neoplasm	0.000496	0.00268	CbGpPWpGaD
Dalfampridine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.00124	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000494	0.00124	CcSEcCtD
Dalfampridine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000489	0.00118	CbGeAlD
Dalfampridine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.00122	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000484	0.00262	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.0012	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000476	0.00119	CcSEcCtD
Dalfampridine—KCNS3—Metabolism—NME1—peripheral nervous system neoplasm	0.000476	0.00257	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NME1—peripheral nervous system neoplasm	0.000476	0.00257	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NME1—peripheral nervous system neoplasm	0.000476	0.00257	CbGpPWpGaD
Dalfampridine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.00119	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—GNS—peripheral nervous system neoplasm	0.00047	0.00254	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—COX2—peripheral nervous system neoplasm	0.000458	0.00247	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—COX2—peripheral nervous system neoplasm	0.000458	0.00247	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—COX2—peripheral nervous system neoplasm	0.000458	0.00247	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000457	0.00114	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—NME1—peripheral nervous system neoplasm	0.000451	0.00244	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000444	0.0024	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00111	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.0011	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—COX2—peripheral nervous system neoplasm	0.000434	0.00235	CbGpPWpGaD
Dalfampridine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00043	0.00108	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00102	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.000996	CcSEcCtD
Dalfampridine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000992	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000395	0.00213	CbGpPWpGaD
Dalfampridine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000954	CcSEcCtD
Dalfampridine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000946	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000945	CcSEcCtD
Dalfampridine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000375	0.00094	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000918	CcSEcCtD
Dalfampridine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000891	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000883	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000875	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000874	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.00087	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—MET—peripheral nervous system neoplasm	0.000333	0.0018	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MET—peripheral nervous system neoplasm	0.000333	0.0018	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000332	0.0018	CbGpPWpGaD
Dalfampridine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000825	CcSEcCtD
Dalfampridine—KCNH2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000324	0.00175	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000308	0.00166	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000308	0.00166	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000301	0.00162	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000301	0.00162	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ENO2—peripheral nervous system neoplasm	0.000301	0.00162	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000296	0.0016	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000285	0.00154	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000282	0.00153	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000282	0.00153	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000279	0.00151	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—BCHE—peripheral nervous system neoplasm	0.000254	0.00137	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000254	0.00137	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000254	0.00137	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000244	0.00132	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000243	0.00131	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000243	0.00131	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000242	0.00131	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000242	0.00131	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000242	0.00131	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000241	0.0013	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TH—peripheral nervous system neoplasm	0.000239	0.00129	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TH—peripheral nervous system neoplasm	0.000239	0.00129	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TH—peripheral nervous system neoplasm	0.000239	0.00129	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—peripheral nervous system neoplasm	0.000237	0.00128	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—peripheral nervous system neoplasm	0.000237	0.00128	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000237	0.00128	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000237	0.00128	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000237	0.00128	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.00023	0.00124	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00023	0.00124	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TH—peripheral nervous system neoplasm	0.000226	0.00122	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000224	0.00121	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000219	0.00119	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000219	0.00119	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000205	0.00111	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000205	0.00111	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000201	0.00109	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000197	0.00107	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GNAS—peripheral nervous system neoplasm	0.000195	0.00105	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000195	0.00105	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000195	0.00105	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000191	0.00103	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000191	0.00103	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000191	0.00103	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000185	0.001	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000185	0.001	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000185	0.000999	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000182	0.000984	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000181	0.00098	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000179	0.000969	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000173	0.000938	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000173	0.000938	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000152	0.000824	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000152	0.000824	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000148	0.000798	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000135	0.000731	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000135	0.000731	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000132	0.000713	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000132	0.000713	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.97e-05	0.000539	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.65e-05	0.000522	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.65e-05	0.000522	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.52e-05	0.000461	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.52e-05	0.000461	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—peripheral nervous system neoplasm	7.59e-05	0.00041	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	7.21e-05	0.00039	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	6.91e-05	0.000374	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	6.65e-05	0.00036	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—peripheral nervous system neoplasm	5.26e-05	0.000284	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—peripheral nervous system neoplasm	5.26e-05	0.000284	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—peripheral nervous system neoplasm	5.26e-05	0.000284	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—peripheral nervous system neoplasm	4.99e-05	0.00027	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	4.37e-05	0.000236	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	3.69e-05	0.000199	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.52e-05	0.00019	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	3.47e-05	0.000188	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	2.83e-05	0.000153	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.78e-05	0.00015	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	7.64e-06	4.13e-05	CbGpPWpGaD
